28 May 2015

Sinclair IS Pharma cuts loss 

22/09/2011 Robert Tyerman

Recently-merged Sinclair IS Pharma (SPH.L) has cut annual losses 31 per cent to £11.7 million and launched an Asia-Pacific marketing drive. The AIM-quoted company, which specialises in oral health, dermatology and wound care, increased turnover 19 per cent to nearly £33 million in the year to June.

Steered by entrepreneurial chief executive Chris Spooner, Sinclair, whose losses before exceptional items rose 14.5 per cent to £5.8 million, achieved several product launches last year. The company introduced its Autopiclair eczema and dermatitis cream into France, a market which returned to growth last year with a 21 per cent turnover gain to £12.5 million, and took its Kelo-cote scar reduction formulation into several European markets.

Outgoing chairman John Gregory says the merger of Sinclair Pharma with IS Pharma should lead to annual cost savings of £1 million and has already started to pay off more positively, as with a marketing agreement for the company's Episil treatment for oral mucositis pain. Grahame Cook, already a Sinclair director, will now chair the company, which has already launched two dermatology products in seven Asia-Pacific countries under its partnership with Singapore-based Invida Holdings, a leader in commercialising bio-pharmaceutical and healthcare products in the region.

Sinclair, which ended the financial year with £5 million cash, now has a 'bio-film busting' mouthwash for sale in the USA under the PerioShield banner through an agreement with Sunstar Americas and has several new products in the pipeline. Highlighted by Growth Company Investor at 28p last autumn, Sinclair shares have eased to 24p, valuing the company at £93.3 million, but could still outperform some sector peers over the medium term.

Tags: AIM market, Asia-Pacifuyc, Autopiclair, Chris Spooner, Dermatology, Wound care

Superb investment toolkit for private investors

SharePad is the new web-based service from ShareScope. Easier to use and more powerful. Perfect for tablets, Macs and Windows PC. Covers ALL your investment requirements.

Growth Company Investor: free trial

Since 2008, our share tips outperformed the benchmark by 281%. Take a free trial and get access to our recommendations today. Start free trial now.

Directors' Pay on AIM 2015

The most comprehensive review of AIM directors' pay available, and this year includes a record sample of 1000+ AIM-quoted companies. The full report is available to order for £385 + VAT. Click here for more info

Latest small-cap and growth company news

Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.

Popular News

Latest News

The Bahamas is one of the richest countries in the Caribbean

Bahamas sees second reading of Petroleum Bill 21/05/2015

Bahamas Petroleum (AIM:BPC) has noted that the Bahamian Parliament  is making progress on passing the Petroleum Bill.

Tags: Bahamas, Oil and gas

Stride joins AIM 21/05/2015

Online bingo operator Stride Gaming has joined AIM in an IPO that raised £11.2 million.

Tags: Gambling, IPOs

Optimal trading well 21/05/2015

Mobile payments specialist Optimal Payments (AIM:OPAY) issued a trading update.

Tags: Mobile payments

Secure Property expands holdings 21/05/2015

Eastern Europe-focused Secure Property Development & Investment has expanded its footprint in Romania and Bulgaria.

Tags: Eastern Europe, Property

Empyrean busy at Sugarloaf 21/05/2015

US oil play Empyrean Energy (AIM:EME) provided a production update on its Sugarloaf project.

Tags: Oil and gas, Texas

Escher's essential product 14/05/2015

Postal service specialist Escher Group (AIM:ESCH) has won a deal to supply its RiposteEssential software.

Tags: Contract win, Technology

More News